Open-label assessment of the long-term tolerability, safety, and efficacy of sertindole in patients with schizophrenia

被引：0
|
作者：
Hale, T. [1 ]
Murray, R. M. [1 ]
Azorin, J. M. [1 ]
Maehlum, E. [1 ]
机构：
[1] St Martins Hosp, Canterbury, Kent, England
来源：
SCHIZOPHRENIA BULLETIN | 2007年 / 33卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：431 / 432
页数：2
相关论文
共 50 条
  • [1] Open-label assessment of the long-term tolerability, safety, and efficacy of sertindole in patients with schizophrenia
    Hale, A.
    Murray, R. M.
    Azorin, J. M.
    Maehium, E.
    EUROPEAN PSYCHIATRY, 2007, 22 : S113 - S113
  • [2] Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia
    Kasper, S
    Brecher, M
    Fitton, L
    Jones, AM
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (05) : 281 - 289
  • [3] Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON)
    Goebel, Hartmut
    Schlegel, Eugen
    Jaeger, Kathrin
    Ortler, Sonja
    Leist, Lea
    JOURNAL OF HEADACHE AND PAIN, 2024, 25 (01):
  • [4] Efficacy and tolerability of long-term (up to 5 years) open-label treatment with aripiprazole in schizophrenia
    Carson, W
    Ali, M
    Saha, A
    McQuade, R
    Owen, R
    Stock, E
    Yamamoto, Y
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S510 - S510
  • [5] LONG-TERM SAFETY AND TOLERABILITY OF LURASIDONE IN PATIENTS WITH SCHIZOPHRENIA: RESULTS OF A 6-MONTH, OPEN-LABEL STUDY
    Stahl, Steven M.
    Cucchiaro, Josephine
    Simonelli, D.
    Severs, J.
    Loebel, A.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 322 - 322
  • [6] An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
    Gahan Pandina
    Stuart Kushner
    Keith Karcher
    Magali Haas
    Child and Adolescent Psychiatry and Mental Health, 6 (1)
  • [7] Long-term safety and tolerability of open-label cariprazine in patients with bipolar I disorder
    Ketter, T. A.
    Sachs, G. S.
    Lu, K.
    Ruth, A.
    Laszlovszky, I.
    Nagy, K.
    Starace, A.
    Durgam, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S377 - S377
  • [8] Long-term safety and tolerability of open-label cariprazine in patients with bipolar I disorder
    Ketter, T. A.
    Sachs, G.
    Lu, K.
    Laszlovszky, I.
    Nagy, K.
    Starace, A.
    Durgam, S.
    BIPOLAR DISORDERS, 2013, 15 : 134 - 134
  • [9] Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: An open-label extension trial
    McConville, B
    Carrero, L
    Sweitzer, D
    Potter, L
    Chaney, R
    Foster, K
    Sorter, M
    Friedman, L
    Browne, K
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2003, 13 (01) : 75 - 82
  • [10] A Long-Term Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults With Schizophrenia
    Forbes, Robert
    Hobart, Mary
    Ouyang, John
    Pfister, Stephanie
    Hakala, Mika
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S409 - S410
12345